Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome (MDS)

Explore clinical trials studying Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

57 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome (MDS) trial results

Completed

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

NCT01772953

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Children's Hospital of Alabama/UAB Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details
Completed

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia

NCT01338337

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Hospital Reina Sofía, Servicio de Hematología Córdoba, Cordoba, Spain
  • Hospital General de Jerez Jerez de la Frontera, Cádiz, Spain
  • Hospital Universitario San Cecilio Granada, Spain
  • Hospital Virgen de las Nieves Granada, Spain
View Trial Details
Completed

Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

NCT00280631

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Loyola University Chicago-Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • University of Massachusetts (UMass) Memorial Medical Center Worcester, Massachusetts, United States
View Trial Details
Completed

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

NCT00502112

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Georgia Cancer Specialists Atlanta, Georgia, United States
View Trial Details
Completed

Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

NCT00700206

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • Wilshire Oncology Medical Group, Inc. La Verne, California, United States
View all 36 locations
View Trial Details

Related conditions